Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia
22-11-2017
Bigul

Sun Pharma net dips by 59% in Q2, US sales down by 47%

Sun Pharmaceutical Industries has received major setback due to lower sales in US during the second quarter ended September 2017.
16-11-2017
Bigul

Sun Pharma: Light at the end of the tunnel

Focus on developing specialty business will prop up growth
15-11-2017
Bigul

Sun Pharma shares dip 4%; market cap drops by Rs 5,065 cr on Q2 numbers

Shares of Sun Pharmaceutical Industries today ended 4 per cent lower after the company reported a 59.19 per cent decline in consolidated net profit for the September quarter of the current fiscal....
15-11-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia
15-11-2017
Bigul

Scheme of Arrangement

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Scheme of Arrangement approved at Board Meeting held on November 14, 2017
14-11-2017
Bigul

Outcome of Committee Meeting

This is to inform you that the Committee of Directors (Allotment) at its meeting held today i.e. on Tuesday, November 14, 2017 allotted 1,260 (One Thousand Two Hundred and Sixty) equity shares of the Company of Re 1/- each, on exercise of stock options under the SUN Employee Stock Option Scheme -2015. Accordingly, post the above allotment the paid-up equity share capital of the Company is Rs. 2,39,93,09,346/- (Rupees Two Hundred and Thirty...
14-11-2017
Bigul

Outcome of Board Meeting

outcome of board meeting is attached.
14-11-2017
Bigul

Sun Pharma: Taro provides some respite

Key triggers are in improvement in ex-Taro performance, resolution of US FDA issues
09-11-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia
06-11-2017
Next Page
Close

Let's Open Free Demat Account